These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 20083001)

  • 1. Diagnosing premotor Parkinson's disease using a two-step approach combining olfactory testing and DAT SPECT imaging.
    Berendse HW; Ponsen MM
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S26-30. PubMed ID: 20083001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olfactory testing combined with dopamine transporter imaging as a method to detect prodromal Parkinson's disease.
    Ponsen MM; Stoffers D; Wolters ECh; Booij J; Berendse HW
    J Neurol Neurosurg Psychiatry; 2010 Apr; 81(4):396-9. PubMed ID: 19965851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiopathic hyposmia as a preclinical sign of Parkinson's disease.
    Ponsen MM; Stoffers D; Booij J; van Eck-Smit BL; Wolters ECh; Berendse HW
    Ann Neurol; 2004 Aug; 56(2):173-81. PubMed ID: 15293269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson's disease.
    Bohnen NI; Gedela S; Kuwabara H; Constantine GM; Mathis CA; Studenski SA; Moore RY
    J Neurol; 2007 Jan; 254(1):84-90. PubMed ID: 17508142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT.
    Stiasny-Kolster K; Doerr Y; Möller JC; Höffken H; Behr TM; Oertel WH; Mayer G
    Brain; 2005 Jan; 128(Pt 1):126-37. PubMed ID: 15548552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyposmia as a marker of (non-)motor disease severity in Parkinson's disease.
    Roos DS; Twisk JWR; Raijmakers PGHM; Doty RL; Berendse HW
    J Neural Transm (Vienna); 2019 Nov; 126(11):1471-1478. PubMed ID: 31515655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion to Parkinson Disease in the PARS Hyposmic and Dopamine Transporter-Deficit Prodromal Cohort.
    Jennings D; Siderowf A; Stern M; Seibyl J; Eberly S; Oakes D; Marek K;
    JAMA Neurol; 2017 Aug; 74(8):933-940. PubMed ID: 28595287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective hyposmia in Parkinson disease: association with hippocampal dopamine activity.
    Bohnen NI; Gedela S; Herath P; Constantine GM; Moore RY
    Neurosci Lett; 2008 Dec; 447(1):12-6. PubMed ID: 18838108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective clinical and DaT-SPECT imaging in premotor
    Sierra M; Martínez-Rodríguez I; Sánchez-Juan P; González-Aramburu I; Jiménez-Alonso M; Sánchez-Rodríguez A; Berciano J; Banzo I; Infante J
    Neurology; 2017 Aug; 89(5):439-444. PubMed ID: 28679601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motor and non-motor correlates of olfactory dysfunction in Parkinson's disease.
    Berendse HW; Roos DS; Raijmakers P; Doty RL
    J Neurol Sci; 2011 Nov; 310(1-2):21-4. PubMed ID: 21705022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pinhole SPECT imaging of dopamine transporters correlates with dopamine transporter immunohistochemical analysis in the MPTP mouse model of Parkinson's disease.
    Andringa G; Drukarch B; Bol JG; de Bruin K; Sorman K; Habraken JB; Booij J
    Neuroimage; 2005 Jul; 26(4):1150-8. PubMed ID: 15908232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcranial sonography of the substantia nigra and its correlation with DAT-SPECT in the diagnosis of Parkinson's disease.
    Li DH; Zhang LY; Hu YY; Jiang XF; Zhou HY; Yang Q; Kang WY; Liu J; Chen SD
    Parkinsonism Relat Disord; 2015 Aug; 21(8):923-8. PubMed ID: 26066091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-motor symptoms and striatal dopamine transporter binding in early Parkinson's disease.
    Liu R; Umbach DM; Tröster AI; Huang X; Chen H
    Parkinsonism Relat Disord; 2020 Mar; 72():23-30. PubMed ID: 32092703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic value of dopamine transporter imaging and olfactory testing in patients with parkinsonian syndromes.
    Georgiopoulos C; Davidsson A; Engström M; Larsson EM; Zachrisson H; Dizdar N
    J Neurol; 2015 Sep; 262(9):2154-63. PubMed ID: 26122543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olfaction and imaging biomarkers in premotor LRRK2 G2019S-associated Parkinson disease.
    Sierra M; Sánchez-Juan P; Martínez-Rodríguez MI; González-Aramburu I; García-Gorostiaga I; Quirce MR; Palacio E; Carril JM; Berciano J; Combarros O; Infante J
    Neurology; 2013 Feb; 80(7):621-6. PubMed ID: 23325906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging prodromal Parkinson disease: the Parkinson Associated Risk Syndrome Study.
    Jennings D; Siderowf A; Stern M; Seibyl J; Eberly S; Oakes D; Marek K;
    Neurology; 2014 Nov; 83(19):1739-46. PubMed ID: 25298306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it?
    Pirker W
    Mov Disord; 2003 Oct; 18 Suppl 7():S43-51. PubMed ID: 14531046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal Change of DAT SPECT in Parkinson's Disease and Multiple System Atrophy.
    Sakakibara S; Hashimoto R; Katayama T; Kenjyo M; Yokokawa Y; Saito Y; Hirakawa A; Ito M; Nakamura T; Hara K; Hashizume A; Aiba I; Inukai A; Katsuno M
    J Parkinsons Dis; 2020; 10(1):123-130. PubMed ID: 31707374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of SPECT imaging of the dopaminergic system in translational research on Parkinson's disease.
    Suwijn SR; de Bruin K; de Bie RM; Booij J
    Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1():S184-6. PubMed ID: 24262177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease.
    Siderowf A; Newberg A; Chou KL; Lloyd M; Colcher A; Hurtig HI; Stern MB; Doty RL; Mozley PD; Wintering N; Duda JE; Weintraub D; Moberg PJ
    Neurology; 2005 May; 64(10):1716-20. PubMed ID: 15911797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.